In reply
The article by Schuller and Govaerts,1 has major differences compared with our study2 regarding the patients treated, mode of treatment, dosage of drug used, and duration of treatment.Schuller and Govaerts1 have treated patients with chronic progressive multiple sclerosis (MS), and their main results are related to the disability of the patients. We have treated pa